microgen
Information Management Solutions
www.microgen.co.uk
5 May 2005
For release at 7:00am
Update on Offer for AttentiV
Microgen plc ('Microgen') notes the announcement made yesterday by TietoEnator
regarding its increased offer for AttentiV Systems Group plc ('AttentiV'),
worth 85.5 pence in cash per AttentiV Share.
As a result of this increased cash offer the Board of Microgen has reviewed its
options. The Board has concluded that it is not in Microgen shareholders'
interest to increase the value of its proposed offer for AttentiV.
Enquiries:
Mike Phillips, Group Finance Director 01753 847122
Nick Adams, UBS Investment Bank 020 7567 8000
Giles Sanderson, Financial Dynamics 020 7831 3113
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.